Bharat biotech, Biotechnology company

Hyderabad, Aug 2 Bharat Biotech on Monday announced that the World Health Organisation (WHO) has awarded prequalification to its rotavirus vaccine, Rotavac 5D.The new variant of Rotavac is a unique rotavirus vaccine formulation that can be administered without a buffer. Its low dose volume (0.5 ml) facilitates easy vaccine logistics, cold chain management and low biomedical waste disposal post-vaccination. It is used for the prevention of rotavirus infection, which is prevalent in infants and young children.WHO prequalification enables the procurement of Rotavac 5D by UN agencies, namely UNICEF and PAHO. It is a validation of the global quality and safety standards required for paediatric vaccines. WHO prequalification of Rotavac 5D will fast-track global access to this life-saving vaccine, the Hyderabad-based company said."Rotavac and Rotavac 5D are projects conceived, innovated, and executed in India; in collaboration with Indian and global partners. This is the culmination of a 30 year effort to develop a novel rotavirus vaccine, resulting in a major advancement in rotavirus disease prevention and reasserts India's leadership in developing and introducing rotavirus vaccines for the world. Today's announcement is an important step to further strengthen and fulfil Bharat Biotech's vision to address neglected diseases and prevent infections that continue to affect millions in the developing world," Bharat Biotech's Joint Managing Director Suchitra Ella said.Bharat Biotech developed the first generation, rotavirus vaccine, Rotavac under a public-private partnership with the Department of Biotechnology, and 16 other international partners, making it the largest ever social innovation project for public health.In the developing world, Rotavac has been instrumental in addressing deaths due to rotavirus, the leading cause of severe diarrhoea among children less than five years of age around the world, resulting in more than 200,000 deaths and 2 million hospitalisations worldwide. Vaccinations are an important part of global public health efforts to meet the Sustainable Developmental Goals of UNDP.Bharat Biotech has so far supplied more than 250 million doses of Rotavac.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Bharat BiotechFOLLOW

Bharat biotech, Latest News

Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month. ...

New Delhi, Aug 10 The Centre on Tuesday approved the Bharat Biotech's Covaxin manufacturing and production facilities at ... ...

Hyderabad, Aug 5 Amid concerns in some quarters about the safety of Covaxin, Bharat Biotech has clarified that ... ...

Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and quality issues, Hyderabad-based manufacturer Bharat Biotech on Thursday said every batch of Covaxin[?] is subjected to more than 200 quality control t ...

Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and quality issues, Hyderabad-based manufacturer Bharat Biotech on Thursday said every batch of Covaxin[?] is subjected to more than 200 quality control t ...

Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities. ...

India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief of National Immunization Technical Advisory Group (NTAGI) said and added that some hiccups like initial difficulties in the new Bangalore plant o ...

Hyderabad, Aug 2 Bharat Biotech on Monday announced that the World Health Organisation (WHO) has awarded prequalification to ... ...